Form 8-K · Current Report · Filed 2024-04-24
Humana Inc. Reports Q1 2024 Financial Results and Revises FY 2024 Guidance
Humana Inc. reported its financial results for the first quarter of 2024, showing a GAAP EPS of $6.11 and an Adjusted EPS of $7.23. The company revised its full-year 2024 GAAP EPS guidance to approximately $13.93, while affirming its Adjusted EPS guidance of approximately $16.00. The earnings release and press details were furnished as Exhibits 99.1 and 99.2.
- Filer
- Humana Inc. HUM · NYSE
- Filed
- Accession
- 0000049071-24-000021
- CIK
- 0000049071
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Results of Operations and Financial Condition
Regulation FD Disclosure
Financial Statements and Exhibits
Market reaction
Close before filing
$327.98
Next session
-5.1%
Since filing
+10.9%
Latest close
$363.86
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from HUM reporting the same item, with the next session's move:
Exhibits (3)
About Humana Inc.
Humana Inc. is a leading healthcare insurance company that primarily focuses on offering comprehensive health insurance products and services. It operates in the insurance sector and is a significant player in the Medicare Advantage market, providing coverage solutions for senior citizens eligible for Medicare. Additionally, Humana boasts a diverse range of health plans, including individual, group medical plans, and specialty products like dental and vision care. The company extends its services to various sectors, including government-sponsored healthcare programs and commercial employers, emphasizing wellness and preventive care. Humana’s offerings are designed to meet the needs of both individual consumers and large organizations, ensuring tailored healthcare coverage. Based in Louisville, Kentucky, Humana is a crucial component of the healthcare system in the United States, striving to improve health outcomes and provide affordable insurance options. The company continues to influence the healthcare industry by enhancing its digital solutions and fostering partnerships that promote integrated care between medical professionals and insurers.
Never miss another HUM filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.